Showing results (11-20 of 6,269) with videos related to
Sort By:
Pageof 627
Diabetes, Obesity & Metabolism|December 18, 2020
ADO09, a co-formulation of the amylin analogue pramlintide and the insulin analogue A21G, lowers postprandial blood glucose versus insulin lispro in type 1 diabetesGrit Andersen, Grégory Meiffren, Susanne Famulla, et al.Diabetes, Obesity & Metabolism|December 24, 2022
Anagliptin twice-daily regimen improves glycaemic variability in subjects with type 2 diabetes: A double-blind, randomized controlled trialYong-Ho Lee, Doo-Man Kim, Jae Myung Yu, et al.Diabetes, Obesity & Metabolism|June 23, 2021
Efficacy and safety of dulaglutide 3.0 and 4.5 mg in patients aged younger than 65 and 65 years or older: Post hoc analysis of the AWARD-11 trialJuan P Frias, Enzo Bonora, Luis Nevárez Ruiz, et al.Diabetes, Obesity & Metabolism|December 17, 2022
Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor/glucagon-like peptide-1 receptor agonist BI 456906Arvid Jungnik, Jorge Arrubla Martinez, Leona Plum-Mörschel, et al.Diabetes, Obesity & Metabolism|January 3, 2023
Lifestyle intervention for the prevention of type 2 diabetes in women with prior gestational diabetes: A systematic review and meta-analysisMatthew Retnakaran, Luciana V Viana, Caroline K KramerDiabetes, Obesity & Metabolism|January 12, 2023
Effects of sodium-glucose cotransporter 2 inhibitors, mineralocorticoid receptor antagonists, and their combination on albuminuria in diabetic patientsRyutaro Morita, Shunichiro Tsukamoto, Shota Obata, et al.Diabetes, Obesity & Metabolism|December 21, 2022
Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once-weekly dosing for the treatment of patients with diabetesTim Heise, Jenny Chien, John M Beals, et al.Diabetes, Obesity & Metabolism|December 22, 2022
IMpact of flash glucose Monitoring in pEople with type 2 Diabetes Inadequately controlled with non-insulin Antihyperglycaemic ThErapy (IMMEDIATE): A randomized controlled trialRonnie Aronson, Ruth E Brown, Lisa Chu, et al.Diabetes, Obesity & Metabolism|December 22, 2022
Validation of a diet-induced Macaca fascicularis model of non-alcoholic steatohepatitis with dietary and pioglitazone interventionsRaul C Camacho, David Polidori, Tao Chen, et al.Diabetes, Obesity & Metabolism|June 6, 2022
Impact of the hepatoselective glucokinase activator TTP399 on ketoacidosis during insulin withdrawal in people with type 1 diabetesKlara R Klein, Schafer C Boeder, Jennifer L R Freeman, et al.Pageof 627